Methylphenidate potentiates morphine-induced antinociception, hyperthermia, and locomotor activity in young adult rats

Pharmacology Biochemistry and Behavior

Volumn 92, Issue 1, 2009, Pages 190-196

  Halladay, Lindsay R ^a   Iñiguez, Sergio D ^a   Furqan, Faiza ^a   Previte, Matt C ^a   Chisum, Ashley M ^a   Crawford, Cynthia A ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Analgesia; Antinociception; Hyperthermia; Locomotor activity; Methylphenidate; Morphine; Ontogeny

Indexed keywords

METHYLPHENIDATE; MORPHINE; OPIATE; OPIATE RECEPTOR; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; FEMALE; HOT PLATE TEST; HYPERTHERMIA; IMMERSION; LOCOMOTION; MALE; NONHUMAN; PERINATAL PERIOD; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; RECTUM TEMPERATURE; REWARD; TAIL;

ANALGESICS, OPIOID; ANIMALS; BODY TEMPERATURE; BODY WEIGHT; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; FEVER; HOT TEMPERATURE; IMMERSION; MALE; METHYLPHENIDATE; MORPHINE; MOTOR ACTIVITY; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTORS, OPIOID, MU;

RATTUS;

EID: 58549106429     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.11.011     Document Type: Article

References (65)

1. Achat-Mendes C., Anderson K.L., and Anderson Y.I. Methylphenidate and MDMA adolescent exposure in mice: long-lasting consequences on cocaine-induced reward and psychomotor stimulation in adulthood. Neuropharmacology 45 (2003) 106-115
2. Andersen S.L. Trajectories of brain development: point of vulnerability or window of opportunity. Neurosci Biobehav Rev 27 (2003) 3-18
3. Andersen S.L. Stimulants and the developing brain. Trends Pharmacol Sci 26 (2005) 237-243
4. Andersen S.L., and Navalta C.P. Altering the course of neurodevelopment: a framework for understanding the enduring effects of psychotropic drugs. Int J Dev Neurosci 22 (2004) 423-440
5. Andersen S.L., Rutstein M., Benzo J.M., Hostetter J.C., and Teicher M.H. Sex differences in dopamine receptor overproduction and elimination. Neuroreport 14 (1997) 1495-1498
6. Andersen S.L., Arvanitogiannis A., Pliakas A.M., LeBlanc C., and Carlezon Jr. W.A. Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nat Neurosci 5 (2002) 13-14
7. Becker J.B. Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol Biochem Behav 64 (1999) 803-812
8. Bernal S.A., Morgan M.M., and Craft R.M. PAG mu opioid activation underlies sex differences in morphine antinociception. Behav Brain Res 177 (2007) 126-133
9. Biederman J., and Faraone S.V. Attention-deficit hyperactivity disorder. Lancet 366 (2005) 237-248
10. Bolaños C.A., Barrot M., Berton O., Wallace-Black D., and Nestler E.J. Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol Psychiatry 54 (2003) 1317-1329
11. Bolaños C.A., Willey M.D., Maffeo M.L., Powers K.D., Kinka D.W., Grausam K.B., et al. Antidepressant treatment can normalize adult behavioral deficits induced by early-life exposure to methylphenidate. Biol Psychiatry 63 (2008) 309-316
12. Brandon C.L., Marinelli M., Baker L.K., and White F.J. Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology 25 (2001) 651-661
13. Broaddus W.C., and Bennett Jr. J.P. Postnatal development of striatal dopamine function. I. An examination of D1 and D2 receptors, adenylate cyclase regulation and presynaptic dopamine markers. Brain Res Dev Brain Res 52 (1990) 265-271
14. Brown R.T., Amler R.W., Freeman W.S., Perrin J.M., Stein M.T., Feldman H.M., et al. American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence. Pediatrics 115 (2005) e749-e757
15. Cadoni C., and Di Chiara G. Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine. Neuroscience 90 (1999) 447-455
16. Caggiula A.R., Epstein L.H., Perkins K.A., and Saylor S. Different methods of assessing nicotine-induced antinociception may engage different neural mechanisms. Psychopharmacology 122 (1995) 301-306
17. Carlezon Jr. W.A., Mague S.D., and Andersen S.L. Enduring behavioral effects of early exposure to methylphenidate in rats. Biol Psychiatry 54 (2003) 1317-1329
18. Centers for Disease Control and Prevention. Mental health in the United States: prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder-United States, 2003. MMWR Morb Mortal Wkly Rep 54 (2005) 842-847
19. Chiu C.T., Ma T., and Ho I.K. Methamphetamine-induced behavioral sensitization in mice: alterations in μ-opioid receptor. J Biomed Sci 13 (2006) 797-811
20. Cicero T.J., Nock B., O'Connor L., and Meyer E.R. Role of steroids in sex differences in morphine-induced analgesia: activational and organizational effects. J Pharmacol Exp Ther 300 (2002) 695-701
21. Coyle J.T., and Campochiaro P. Ontogenesis of dopaminergic-cholinergic interactions in the rat striatum: a neurochemical study. J Neurochem 27 (1976) 673-678
22. Craft R.M., Clark J.L., Hart S.P., and Pinckney M.K. Sex differences in locomotor effects of morphine in the rat. Pharmacol Biochem Behav 85 (2006) 850-858
23. Crawford C.A., Villafranca S.W., Cyr M.C., Farley C.M., Reichel C.M., Gheorghe S.L., et al. Effects of early methylphenidate exposure on morphine- and sucrose-reinforced behaviors in adult rats: relationship to dopamine D2 receptors. Brain Res 1139 (2007) 245-253
24. Di Chiara G., and Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85 (1988) 5274-5278
25. Espejo E.F., and Mir D. Structure of the rat's behavior in the hot plate test. Behav Brain Res 56 (1993) 171-176
26. Filliol D., Ghozland S., Chluba J., Martin M., Matthes H.W.D., Simonin F., et al. Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet 25 (2000) 195-200
27. Flores J.A., Banousa F.E., Galán-Rodríguez, and Fernandez-Espejo E. Opiate anti-nociception is attenuated following lesion of large dopamine neurons of the periaqueductal grey: critical role for D1 (not D2) dopamine receptors. Pain 110 (2004) 205-214
28. Gioiosa L., Chen X., Watkins R., Klanfer N., Bryant C.D., Evan C.J., et al. Sex chromosomes complement affects nociception in tests of acute and chronic exposure to morphine in mice. Horm Behav 53 (2008) 124-130
29. Giorgi O., De Montis G., Porceddu M.L., Mele S., Calderini G., Toffano G., et al. Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatum. Brain Res 432 (1987) 283-290
30. Gleanson M.M., Egger H.L., Emslie G.J., Greenhill L.L., Kowatch R.A., Lieberman A.F., et al. Psychopharmacological treatment for very young children: contexts and guidelines. J Am Acad Child Adolesc Psychiatry 46 (2007) 1532-1572
31. Gray J.D., Punsoni M., Tabori N., Melton J.T., Fanslow V., Ward M.J., et al. Methylphenidate administration to juvenile rats alters brain areas involved in cognition, motivated behaviors, appetite, and stress. J Neurosci 27 (2007) 7196-7207
32. Greenhill L.L., Posner K., Vaughan B.S., and Kratochvil C.J. Attention deficit hyperactivity disorder in preschool children. Child Adolesc Psychiatr Clin N Am 17 (2008) 347-366
33. Hammer Jr. R.P. Cocaine alters opiate receptor binding in critical brain reward regions. Synapse 3 (1989) 55-60
34. Hechtman L., and Greenfield B. Long-term use of stimulants in children with attention deficit hyperactivity disorders: safety, efficacy, and long-term outcome. Paediatr Drugs 5 (2003) 787-794
35. Kalinichev M., White D.A., and Holtzman S.G. Individual differences in locomotor reactivity to a novel environment and sensitivity to opioid drugs in the rat. I. Expression of morphine-induced locomotor sensitization. Psychopharmacology 177 (2004) 61-67
36. Kest B., Adler M., and Hopkins E. Sex differences in thermoregulation after acute and chronic morphine administration in mice. Neurosci Lett 291 (2000) 126-128
37. King S., Griffin S., Hodges Z., Weatherly H., Asseburg C., Richardson G., et al. A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents. Health Technol Assess 10 (2006) 1-146
38. Kratochvil C.J., Greenhill L.L., March J.S., Burke W.J., and Vaughan B.S. The role of stimulants in the treatment of preschool children with attention-deficit hyperactivity disorder. CNS Drugs 18 (2004) 957-966
39. Krzanowska E.K., and Bodnar R.J. Morphine antinociception elicited from the ventrolateral periaqueductal gray is sensitive to sex and gonadectomy differences in rats. Brain Res 821 (1999) 224-230
40. Lambert N.M., and Hartsough C.S. Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. J Learn Disabil 31 (1998) 533-544
41. Le Bars D., Gozariu M., and Cadden S.W. Animal models of nociception. Pharmacol Rev 53 (2001) 597-652
42. Mannuzza S., Klein R.G., and Moulton III J.L. Does stimulant treatment place children at risk for adult substance abuse? A controlled, prospective follow-up study. J Child Adolesc Psychopharmacol 13 (2003) 273-282
43. Mannuzza S., Klein R.G., Troung N.L., Moulton III J.L., Roizen E.R., Howell K.H., et al. Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood. Am J Psychiatry 165 (2008) 604-609
44. Mogil J.S., Chesler E.J., Wilson S.G., Juraska J.M., and Sternberg W.F. Sex differences in thermal nociception and morphine antinociception in rodents depend on genotype. Neurosci Biobehav Rev 24 (2000) 375-389
45. Murrin L.C., and Zeng W.Y. Ontogeny of dopamine D1 receptors in rat forebrain: a quantitative autoradiographic study. Brain Res Dev Brain Res 57 (1990) 71-73
46. Murrin L.C., and Zeng W. Postnatal ontogeny of dopamine D2 receptors in rat striatum. Biochem Pharmacol. 35 (1986) 1159-1162
47. National Research Council. Guidelines for the care and use of mammals in neuroscience and behavioral research (2003), Washington:National Academy Press
48. Ognibene E., Adriani W., Granstrem O., Pieretti S., and Gaviola G. Impulsivity-anxiety-related behavior and profiles of morphine-induced analgesia in heterozygous reeler mice. Brain Res 1131 (2007) 173-180
49. Paul D., Bodnar R.J., Gistrak M.A., and Pasternak G.W. Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice. Eur J Pharmacol 168 (1989) 307-314
50. Peckham E.M., Barkley L.M., Divin M.F., Cicero T.J., and Traynor J.R. Comparison of the antinociceptive effect of acute morphine in female and male Sprague-Dawley rats using the long-lasting mu-antagonist methocinnamox. Brain Res 1058 (2005) 137-147
51. Quock R.M., Vaughn L.K., Barlament J., and Wojcechowskyj J.A. Sex and strain differences in morphine-induced temperature effects in WKYs and SHRs. Brain Res Bull 14 (1985) 323-326
52. Rawls S.M., Adler M.W., Gaughan J.P., Baron A., Geller E.B., and Cowan A. NMDA receptors modulate morphine-induced hyperthermia. Brain Res 984 (2003) 76-83
53. Rao P.A., Molinoff P.B., and Joyce J.N. Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study. Brain Res Dev Brain Res 21 (1991) 161-177
54. Schroeder J.A., Niculescu M., and Unterwald E.M. Cocaine alters mu but not delta or kappa opioid receptor-stimulated in situ [35S]GTPγS binding in rat brain. Synapse 47 (2003) 26-32
55. Tarazi F.I., and Baldessarini R.J. Comparative postnatal development of dopamine D(1), D(2) and D(4) receptors in rat forebrain. Int J Dev Neurosci 18 (2000) 29-37
56. Teicher M.H., Andersen S.L., and Hostetter Jr. J.C. Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens. Brain Res Dev Brain Res 89 (1995) 167-172
57. Unterwald E.M., Horne-King J., and Kreek M.J. Chronic cocaine alters brain mu opioid receptors. Brain Res 584 (1992) 314-318
58. Unterwald E.M., Rubenfeld J.M., and Kreek M.J. Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors. Neuroreport 5 (1994) 1613-1616
59. Vanderschuren L.J.M.J., De Vries T.J., Wardeh G., Hogenboom F.A.C.M., and Schoffelmeer A.N.M. A single exposure to morphine induces long-lasting behavioural and neurochemical sensitization in rats. Eur J Neurosci 14 (2001) 1533-1538
60. Vanderschuren L.J.M.J., Schoffelmeer A.N.M., Mulder A.H., and De Vries T.J. Lack of cross-sensitization of the locomotor effects of morphine in amphetamine-treated rats. Neuropsychopharmacology 21 (1999) 550-559
61. Vaughan B.S., Wetzel M.W., and Kratochvil C.J. Beyond the 'typical' patient: treating attention-deficit/hyperactivity disorder in preschoolers and adults. Int Rev Psychiatry 20 (2008) 143-149
62. Vergura R., Balboni G., Spagnolo B., Gavioli E., Lambert D.G., McDonald J., et al. Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist. Peptides 29 (2008) 93-103
63. Waldhoer M., Bartlett S.E., and Whistler J.L. Opioid receptors. Annu Rev Biochem 73 (2004) 953-990
64. Walker Q.D., Rooney M.B., Wightman R.M., and Kuhn C.M. Dopamine release and uptake are greater in female than male rat striatum as measured by cyclic voltammetry. Neuroscience 95 (2000) 1061-1070
65. Wilens T.E., Faraone S.V., Biederman J., and Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 111 (2003) 179-185